OTC: DSKYF - Daiichi Sankyo Company, Limited

Yield per half year: +7.39%
Sector: Healthcare

Daiichi Sankyo Company, Limited

Underestimation
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
3/10
47.11 117.69 -59.97% 42.73 10.25%
P/S 5.9 8.16 -27.67%
P/BV 5.57 3.37 65.24%
P/FCF 0.1287 160.84 -99.92%
Ev/Ebitda 36.75 52.39 -29.85%
Ev/S 5.74 6.96 -17.52%
Ev/FCF 19.3 142.77 -86.48%
E/P 3.27 1.47 122.8%
Efficiency
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
5/10
15.62 24.93 -37.34% 15.3 2.11%
ROE 11.89 12.96 -8.26%
ROA 5.8 6.09 -4.81%
ROIC 11.02 15.56 -29.19%
ROS 12.53 12.55 -0.1683%
ROCE 10.95 16.88 -35.11%
Debt
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
0.4562 143.57 -99.68% 1.04 -56.15%
Nеt Debt/Ebitda -1.04 -5.05 -79.49%
Debt/Ratio 0.033 0.4053 -91.86%
Debt/Equity 54.88 11.8 365.26%
Debt/Net Income 0.5687 147.58 -99.61%
Dividends
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
4.98/10
1.99 1.73 14.75% 1.12 77.07%
Number of years of dividend growth 2 1.07 86.84%
DSI 0.9286 0.7807 18.94%
Average dividend growth 16.82 -79.6 -121.14%
Average percentage for 5 years 1.12 2.81 -60.04%
Average percentage for payments 70.58 247.07 -71.43%
Difference from average difference in sector 0.2558
Growth impulse
Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue 5 years
8/10
63.14 180.62 -65.04%
Growth impulse Ebitda 5 years 46.65 201.95 -76.9%
Growth impulse Net Income 5 years 55.52 160.03 -65.31%
Growth impulse FCF 5 years 230.8 118.65 94.52%
Growth impulse EPS 5 years 57.56 280.49 -79.48%
IP Score
6.17/10

Similar companies

WuXi Biologics (Cayman) Inc.

Sinopharm Group Co., Ltd.

Roche Holding

Sinopharm Group Co., Ltd.